Think fast! Your patient relapsed after BCMA CAR T... now what?
Need a #rewind? Listen now at bit.ly/4l6Gm2s.
#HemeTalks #MultipleMyeloma #BCMATherapy #CAR_T #RelapsedMyeloma #Hematology #ASHEducation #medicalpodcast #CAR_TResistance
Need a #rewind? Listen now at bit.ly/4l6Gm2s.
#HemeTalks #MultipleMyeloma #BCMATherapy #CAR_T #RelapsedMyeloma #Hematology #ASHEducation #medicalpodcast #CAR_TResistance
August 28, 2025 at 2:48 PM
Think fast! Your patient relapsed after BCMA CAR T... now what?
Need a #rewind? Listen now at bit.ly/4l6Gm2s.
#HemeTalks #MultipleMyeloma #BCMATherapy #CAR_T #RelapsedMyeloma #Hematology #ASHEducation #medicalpodcast #CAR_TResistance
Need a #rewind? Listen now at bit.ly/4l6Gm2s.
#HemeTalks #MultipleMyeloma #BCMATherapy #CAR_T #RelapsedMyeloma #Hematology #ASHEducation #medicalpodcast #CAR_TResistance
Featured today by @MSKLibrary: Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies dx.doi.org/10.2147/PPA....
#MultipleMyeloma #RelapsedMyeloma
#RefractoryMyeloma #CancerCare #Hematology
#Oncology #CancerAwareness
#MultipleMyeloma #RelapsedMyeloma
#RefractoryMyeloma #CancerCare #Hematology
#Oncology #CancerAwareness
May 20, 2025 at 4:30 PM
Featured today by @MSKLibrary: Perspectives of Healthcare Providers and Patients with Relapsed/Refractory Multiple Myeloma on Treatment Priorities and Novel Therapies dx.doi.org/10.2147/PPA....
#MultipleMyeloma #RelapsedMyeloma
#RefractoryMyeloma #CancerCare #Hematology
#Oncology #CancerAwareness
#MultipleMyeloma #RelapsedMyeloma
#RefractoryMyeloma #CancerCare #Hematology
#Oncology #CancerAwareness
#Haematology #oncology #Talvey #Scotland #relapsedandrefractorymultiplemyeloma #multiplemyeloma #SMC #JnJ #ScottishMedicinesConsortium #NHSScotland #antiCD38antibody #bloodcancer #MonumenTAL1study #relapsedmyeloma #bispecifictherapy #MyelomaUK #GPRC5Dexpressingmyelomacells
zurl.co/YbEvY
zurl.co/YbEvY
Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma - PharmaTimes
SMC backs first GPRC5D‑targeting bispecific for patients after three or more treatments
pharmatimes.com
June 11, 2026 at 8:14 AM